Procarbazine Hydrochloride Capsule (Natulan®) Clinical Trial Protocol

• Status: Unknown status
• Trial end date: 2018-12-01

Summary

1. To observe and compare the overall response rate (ORR) of baseline BEACOPP and ABVD regimens for patients with advanced Hodgkin's lymphoma.

2. To evaluate the safety of Natulan® in Chinese patients with advanced Hodgkin's lymphoma

• Phase: N/A

Details

• Lead Sponsor: Lee's Pharmaceutical Limited
• Treatments: Doxorubicin; Procarbazine